SCRC......ScripsAmerica Inc. and a Startling off the charts

New Post Public Reply Private Reply Replies (2) Message Board
tryz
SCRC......ScripsAmerica Inc. and a Startling off the charts to revenue growth to 'ONE' BUSINESS OPERATION - New Press Release this morning!!!.....Kaboom!!!.....Loyal Shareholders Win....> May 5, 2014 - 8:30 AM EDT

Monthly Revenue From ScripsAmerica's Managed Specialty Pharmacy Nearly Doubles in April, Topping $958,000
TYSONS CORNER, Va., May 5, 2014 (GLOBE NEWSWIRE) -- ScripsAmerica, Inc. (OTCBB:SCRC) today announced that its managed specialty pharmacy reported $958,234 in prescription sales during the month of April, representing a 94% increase in monthly revenue over March.

The specialty pharmacy, which focuses on compounding topical creams, has generated a total of $1,600,501 in sales since ScripsAmerica entered an agreement to manage its operations in exchange for a very significant percentage of its revenues in February. April's figures give the pharmacy an annual run rate of $11.5 million.

Bob Schneiderman, the Company's CEO, stated, "We are very pleased to report that ScripsAmerica's managed specialty pharmacy set a revenue record in April, nearly doubling its sales from March. This demonstrates significant rapid revenue growth and further, we believe that the Company has not nearly tapped the potential of this endeavor. There are several factors that we believe will drive steady revenue growth for this pharmacy."

"First, topical creams are experiencing growing demand as an effective alternative to pills that can be more easily ingested in higher doses than originally prescribed. Secondly, our pharmacy utilizes a new system to process prescriptions that have greatly increased its efficiency, sales, profitability, etc. Finally, under our management, the specialty pharmacy has applied for licensing in additional states, which will enable continued growth in both our revenues and profits from this operation," continued Schneiderman.


About ScripsAmerica, Inc.

ScripsAmerica, Inc. is a supplier of prescription, OTC and nutraceutical drugs, delivering pharmaceutical products to a wide range of end users across the health care industry. End users include retail pharmacies, hospitals, long-term care facilities and government and home care agencies. For more information, visit www.ScripsAmerica.com.

ScripsAmerica Inc (SCRC) Stock Research Links

SCRC Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Wells Fargo Adjusts American Tower's Position Amid Changes

Updated Category News Views 81

Wells Fargo's Recent Adjustments on American Tower Corporation In a recent move, Wells Fargo has made notable adjustments regarding American Tower Corporation (NYSE: AMT). The financial institution has downgraded the company’s stock from Overweight to Equal Weight while also reducing its price target to $230, down from $245. This decision stems from certain...

Continue Reading
WeightWatchers Completes Major Changes and Innovates Women's Health

Updated Category News Views 352

WeightWatchers Strengthens Leadership and Expands Health Initiatives WeightWatchers is making headlines as it completes a significant financial reorganization, enhancing its operational capabilities and leadership. With the appointment of respected figures in the health industry, including Dr. Kim Boyd as Chief Medical Officer, the Company aims to expand its services and...

Continue Reading
Understanding Short Interest Trends for FactSet Systems

Updated Category News Views 493

Unpacking the Short Interest for FactSet Research Systems FactSet Research Systems's short percent of float has seen a decline of 7.56% since its last report, reflecting a changing sentiment among traders. The recent data indicates that the company currently has 2.16 million shares sold short, equating to 6.48% of all its regular shares available for trading. Looking at...

Continue Reading
Investor Insights: Bausch + Lomb Faces Scrutiny Over Stock Drop

Updated Category News Views 177

Investor Insights: Bausch + Lomb Faces Scrutiny Over Stock Drop Bausch + Lomb Corporation, known for its high-quality vision and eye health products, has recently come under fire as Pomerantz LLP initiates a probe on behalf of its investors. This legal investigation stems from potential securities fraud or other irregularities that may affect the company’s integrity and...

Continue Reading
EquipmentShare IPO Lawsuit: Implications for EQPT Investors

Updated Category News Views 7

EquipmentShare Faces Legal Storm Alright folks, plenty of us have been around the block long enough to know that when a new IPO gets hitched up to a lawsuit train, you better sit up and take notice. EquipmentShare.com, Inc. (NASDAQ:EQPT), a name that not too long ago was supposed to be a hotshot player in the cloud-based equipment rental game, is knee-deep in legal muck...

Continue Reading